After big merger, Big Pharma trims projects — and a potential $1 billion payment — from collaboration with small Peninsula biotech
February 26, 2019 at 17:28 PM EST
When Big Pharma sneezes, small biotechs can catch a cold that can shed millions of dollars in potential "bio bucks."
